SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 57 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q1 2018$17,000
-29.2%
52,131
+11.0%
0.01%
-28.6%
Q4 2017$24,000
-44.2%
46,981
+2.2%
0.01%
-50.0%
Q3 2017$43,000
+87.0%
45,981
+14.4%
0.01%
+75.0%
Q2 2017$23,000
+43.8%
40,181
+60.4%
0.01%
-11.1%
Q1 2017$16,0000.0%25,050
+16.2%
0.01%0.0%
Q4 2016$16,000
-23.8%
21,550
+75.9%
0.01%
-25.0%
Q3 2016$21,00012,2500.01%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,998,941$5,839,0002.81%
Knoll Capital Management, LLC 3,400,816$4,965,0001.95%
Third Security, LLC 12,300,768$17,960,0000.82%
MSD Partners, L.P. 3,583,500$5,232,0000.12%
Genesis Wealth Advisors, LLC 35,000$78,750,0000.06%
THOMPSON DAVIS & CO., INC. 20,000$29,0000.03%
TFS CAPITAL LLC 157,800$230,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$35,0000.01%
WEDBUSH SECURITIES INC 12,000$18,0000.00%
REGIONS FINANCIAL CORP 100,000$146,0000.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders